Furukawa et al. also highlighted that analyses of immunohistochemical stainings of tumor-infiltrating CD8+ (lymphocytes) and CD14+ (monocytes) cells were conducted, and a “CD8+/CD14+” ratio was calculated. The gene discussed is CD8A; the disease is neoplasm.